EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
Abstract Enhancer of zeste homolog 2 (EZH2) is often increased in malignant tumors and is involved in metastasis. EZH2 silences gene expression by tri-methylating the lysine 27 residue of histone H3 (H3K27me3). However, the mechanism underlying EZH2 promotion of ovarian cancer metastasis remains elu...
Guardado en:
Autores principales: | Xiaoqing Yi, Jianfeng Guo, Jing Guo, Si Sun, Ping Yang, Junjie Wang, Yuan Li, Lisha Xie, Jing Cai, Zehua Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/73dc2287caf146d6a51c6c9b7f2edf27 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
P38α/JNK signaling restrains erythropoiesis by suppressing Ezh2-mediated epigenetic silencing of Bim
por: Ping Hu, et al.
Publicado: (2018) -
EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop
por: Wendy Béguelin, et al.
Publicado: (2017) -
Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
por: Katharina Leitner, et al.
Publicado: (2020) -
CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity
por: Sergey Karakashev, et al.
Publicado: (2018) -
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A
por: Jin Wang, et al.
Publicado: (2021)